Pathogenic mitochondrial DNA mutations are associated with ROS signature and are prognostic markers in hepatocellular carcinoma

Pathogenic mitochondrial DNA mutations are associated with ROS signature and are prognostic markers in hepatocellular carcinoma

Pathogenic mitochondrial DNA mutations are associated with ROS signature and are prognostic markers in hepatocellular carcinoma 1125 1625 Metabolism & Cancer

Camelia Coada

Download PDF
Email
Forced lipid catabolism entails higher proliferation rate of cervical cancer cells by ROS-dependent HIF1α activation
Loss of glutaredoxin-2 contributes to tumor oncocytic transformation via differential protein s-glutathionylation and hampering of oxidative phosphorylation
The role of adipocyte G0/G1 Switch Gene 2 (G0S2) in the crosstalk between cancer cells and adipocytes
Mitochondrial complex I null cancer models reveal unspecific antiproliferative effects of complex I inhibitors – Copie
Enter your
text here